A part of Watch Media

MedWatchSaturday4 February 2023

  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
Luja can potentially solve a long-lived UTI problem for people who need help with bladder control issues by using new micro-hole technology

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

A male catheter is the Danish medtech company’s biggest launch in half a decade – and CFO Anders Lonning-Skovgaard expects the 12-month rollout to be nothing but smooth sailing.
  • Coloplast to take quantum leap in core markets with new high-tech products
  • Coloplast launches male catheter featuring new technology

For subscribers

Nu mangler kun en endelig vedtagelse i EU-Parlamentet, før lovforslag om at udskyde deadlines for nye krav til medicinsk udstyr. er en realitet. | Foto: Thomas Borberg/Ritzau Scanpix

Another hurdle overcome in delaying MDR deadline

For subscribers

Foto: Coloplast/pr

Coloplast launches male catheter featuring new technology

For subscribers

Foto: Coloplast / Pr

Coloplast's bottom line disappoints in otherwise strong report

For subscribers

Foto: Asensus Surgical/pr

Asensus Surgical wins CE Mark for intelligent surgical unit under MDR rules

For subscribers

Foto: Yves Herman

EU Commission to give more time for MDR transition

For subscribers

  • Coloplast still has to get products equaling 20% of the company's revenues approved under the EU's new strict rules | Foto: Coloplast / Pr

    Coloplast's products generating 80% of revenue have been MDR approved

    For six years, the Danish medtech company has been increasing its number of employees tasked with ensuring products comply with new EU regulation – but there’s still a ways to go.

    For subscribers

  • Foto: Coloplast / Pr

    Coloplast agrees to million-dollar settlement in the US

    Following its own report of possible violations in connection with sales to US military veterans, the Danish medical technology company agrees to million-dollar settle claims.

    For subscribers

  • Foto: Unilabs / Pr

    Unilabs and Siemens Healthineers enter million-euro strategic partnership

    The diagnostic services provider is buying Siemens Healthineers-developed equipment valued at EUR 200m.

    For subscribers

  • Foto: Coloplast / Pr

    Analyst: China headwinds will dampen Coloplast's first quarter

    Covid-19 shutdowns in China have restricted patients’ hospital access, which Danish bank Sydbank says will hurt revenue inflows for the Danish medtech company.

    For subscribers

  • Foto: Marcio Jose Sanchez/AP/Ritzau Scanpix

    Boston Scientific's endoscope sales beat predictions

    The US-based medtech firm’s outlook for 2023 is a tad less optimistic than what analysts had hoped for.

    For subscribers

  • Foto: Medtrace / Pr

    Medtrace wins US patent on new heart imaging method

    A new patented software developed by the diagnostics firm is one part of a ”unique way of modelling the human heart” – a ”milestone” for Medtrace, though it’s unclear on when the system is marketable.

    For subscribers

  • Katrine Hammer (right), chief executive officer of Philips Medisize A/S in Denmark and vice president for global innovation and development in Europe | Foto: Phillips-medisize

    US medtech group expands production in Denmark

    In just a few years, Phillips-Medisize has doubled its staffing, and is now expanding its production facility in Danish town Struer to keep up with demand.

    For subscribers

  • Foto: Coloplast / Pr

    Coloplast is the world's most sustainable medtech firm in new analysis

    Among 87 of the largest, publicly listed medtech companies, Coloplast has been deemed the very best on sustainability, according to a new international ranking. 

    For subscribers

  • Foto: Ambu/pr

    Ambu silent on Russian exit issues

    In December, Ambu CEO Britt Meelby Jensen briefly noted that shutting down Russian activities was not going according to plan – and she does not want to say more than that today.

    For subscribers

  • Stine Dahl, COO and CFO of RSP Systems | Foto: Rsp Systems

    Danish medtech firm partners with German giant to eliminate needles in blood sugar testing

    RSP Systems wants to offer a needle-free way for diabetics to monitor their glucose levels, and a billion-dollar German corporation is ready to help them reach the goal.

    For subscribers

  • Foto: Ambu/pr

    Renewed optimism could be behind Ambu trading surge, says analyst

    So far in 2023, the medtech company’s shares have gone up 20% on the exchange. A Sydbank analyst points to a number of factors for why.

    For subscribers

  • Steven Russell, incoming chief medical officer at Beta Bionics | Foto: Beta Bionics/PR

    Bionic pancreas system nears commercial launch

    The biotech company, a partner of Novo Nordisk and Zealand Pharma, among others, hires a chief medical officer ahead of a commercial launch of the bionic pancreas system. 

    For subscribers

  • The medtech industry is feeling the inflation pressure particularly hard as companies cannot usually adjust product prices due to year-long fixed contracts

    Inflation has medtech industry in tight squeeze

    High inflation is putting pressure on medtech companies that operate in an industry characterized by fixed product prices under year-long contracts. An uncertain year is ahead, reflected in the companies’ financial expectations.

    For subscribers

  • Foto: Novo Holdings / PR

    Novo Holdings invests in Danish medtech firm

    The Novo Nordisk owner is stepping into the ownership circle of Evosep with an investment that will facilitate the company’s US market entry.

    For subscribers

  • Foto: Coloplast / Pr

    Analyst: Better conditions in China to ease Coloplast's cost pressure

    Coloplast has been intensely focused on costs as of late, but Danske Bank now thinks a Chinese relaxation of pandemic restrictions will dispel the worst concerns. 

    For subscribers

  • Though Ambu decided to establish its Mexico plan before the pandemic, the decision to do so has only grown in importance after Covid-19 struck | Foto: Ambu / Pr

    Pandemic made Mexico plant more desirable, says Ambu CEO

    In an increasingly uncertain world, having production closer to one’s most important market is just one of the many advantages of the factory in Mexico, says Britt Meelby Jensen, CEO of Ambu.

    For subscribers

  • Foto: Getinge / Pr

    JPMorgan spots challenging first quarter for European medtech firms

    Several medtech companies in Europe have been given the ”underweight” recommendation by JPMorgan.

    For subscribers

  • Foto: Stine Bidstrup

    Operating costs and development in China key focal points for Coloplast in 2023

    Energy costs as well as prices on raw materials are among focal points for Coloplast in 2023, while the medical technology company also pivots on ongoing developments in China. 
  • Lars Rasmussen, chairman of the board at Coloplast | Foto: Thomas Emil Sørensen/ERH

    Coloplast chair profits millions of kroner from share options

    This week, Lars Rasmussen, Coloplast chair, bought a batch of Coloplast shares exercising his options, and sold them soon after at million-kroner plus.

    For subscribers

  • Olympus to acquire AI endoscopy startup

    For around USD 79m, Odin Vision and its cloud-AI platform for endoscopy procedures will come into the fold of Japanese endoscopy giant Olympus.

    For subscribers

Latest news

  • Top news from MedWatch this week – 3 Feb
  • Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps – 3 Feb
  • China accepts regulatory filing for ALK allergy tablet – 3 Feb
  • Another hurdle overcome in delaying MDR deadline – 3 Feb
  • Dupixent becomes ninefold blockbuster – 3 Feb
  • ALK forecasts lower growth in 2023 than strong 2022 result – 3 Feb
  • Unilabs and Siemens Healthineers enter million-euro strategic partnership – 3 Feb
  • Coloplast launches male catheter featuring new technology – 3 Feb
  • Novo Nordisk hopes to retain employees with share gift – 3 Feb
  • Coloplast's bottom line disappoints in otherwise strong report – 3 Feb
See all

Jobs

  • Supply Chain Manager

  • Medical Advisor (Metabolism)

  • Commercial Director

  • Senior Health Economics and Outcomes Research (HEOR) Manager

  • Senior Clinical Project Manager

  • Lead Data Architect

  • Application Manager

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Clinical Operational Associate

  • Experienced Patent Counsel

  • Regulatory Affairs Professional

  • Application Manager

  • Sr. Director, Drug Safety Physician

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Google ChromeMozilla FirefoxMicrosoft Edge